Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
about
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancerFluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityFluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityEvaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasisMajor combined electrolyte deficiency during therapy with low-dose cisplatin, 5-fluorouracil and interferon alpha: report on several cases and review of the literature [ISRCTN62866759].IP(3) receptor antagonist, 2-APB, attenuates cisplatin induced Ca2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis.Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments.N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models.Vitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model.Evidence against protective role of sex hormone estrogen in Cisplatin-induced nephrotoxicity in ovarectomized rat model.An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures.The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect.Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy.Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance.
P2860
Q24197545-62DF0A36-1C57-44C1-8B25-4F9F4A5F2355Q24236119-1B18DBBD-86D2-40DE-AAB4-701459185357Q24242032-2E8C6B4B-2641-461D-8537-3C4345F3A009Q28483086-7018374B-F239-4D52-AAAC-BD49A8A325B6Q33243003-EE8880F0-767F-4161-8FE3-3752D2D476FAQ33288844-84A047EB-A36E-4E85-AD1C-F821EC2FB0DCQ33645678-892A2257-7748-4A74-A0A0-8BF195AB5F13Q35071886-256FDC22-8758-4FBB-A91B-E26A0DF219A2Q36296439-C6B3285C-EF30-4C34-AB52-9EBFA86B343BQ36984545-262590EC-713E-4220-846F-683D0153550BQ38975452-547636F2-C9F3-4D06-BBE5-F49F92B7DC42Q41879041-FDEEA1B1-9F9B-4F8C-85E8-7B45C2106FEAQ46593132-68D162F6-2F0D-409A-9C38-F35F5BA69DBBQ48244563-C84BFDE3-DF8B-400B-AB5F-F98F7403DE02
P2860
Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
@ast
Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
@en
type
label
Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
@ast
Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
@en
prefLabel
Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
@ast
Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
@en
P356
P1476
Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
@en
P2093
Marshall P Goren
P304
P356
10.1002/MPO.10335
P577
2003-09-01T00:00:00Z